Targeted magnetic nanoparticles for mechanical lysis of tumor cells by low-amplitude alternating magnetic field

Adi Vegerhof, Eran A. Barnoy, Menachem Motiei, Dror Malka, Yossef Danan, Zeev Zalevsky, Rachela Popovtzer

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Currently available cancer therapies can cause damage to healthy tissue. We developed a unique method for specific mechanical lysis of cancer cells using superparamagnetic iron oxide nanoparticle rotation under a weak alternating magnetic field. Iron oxide core nanoparticles were coated with cetuximab, an anti-epidermal growth factor receptor antibody, for specific tumor targeting. Nude mice bearing a head and neck tumor were treated with cetuximab-coated magnetic nanoparticles (MNPs) and then received a 30 min treatment with a weak external alternating magnetic field (4 Hz) applied on alternating days (total of seven treatments, over 14 days). This treatment, compared to a pure antibody, exhibited a superior cell death effect over time. Furthermore, necrosis in the tumor site was detected by magnetic resonance (MR) images. Thermal camera images of head and neck squamous cell carcinoma cultures demonstrated that cell death occurred purely by a mechanical mechanism.

Original languageEnglish
Article number943
JournalMaterials
Volume9
Issue number11
DOIs
StatePublished - 22 Nov 2016

Bibliographical note

Publisher Copyright:
© 2016 by the authors.

Keywords

  • Biomedical
  • Cetuximab
  • Head and neck cancer
  • MRI
  • Magnetic field

Fingerprint

Dive into the research topics of 'Targeted magnetic nanoparticles for mechanical lysis of tumor cells by low-amplitude alternating magnetic field'. Together they form a unique fingerprint.

Cite this